🇺🇸 FDA
Patent

US 8252937

1,3-disubstituted 4-(aryl-X-phenyl)-1H-pyridin-2-ones

granted A61KA61K47/06A61K47/10

Quick answer

US patent 8252937 (1,3-disubstituted 4-(aryl-X-phenyl)-1H-pyridin-2-ones) held by Addex Pharma, S.A. expires Mon Aug 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Addex Pharma, S.A.
Grant date
Tue Aug 28 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K47/06, A61K47/10, A61K9/0019, A61K9/0095